Cite
APA Citation
Gibbs, J. P., Slatter, J. G., Egbuna, O., Geller, M., Hamilton, L., Dias, C. S., Xu, R. Y., Johnson, J., Wasserman, S. M., & Emery, M. G. (2017). evaluation of Evolocumab (AMG 145), a Fully Human Anti‐PCSK9 IgG2 Monoclonal Antibody, in Subjects With Hepatic Impairment. Journal of clinical pharmacology, 57, 513–523. http://access.bl.uk/ark:/81055/vdc_100042795814.0x00005d